PolyNovo
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
1998Stage
IPO | IPODate of IPO
11/26/1998Market Cap
1.34BRevenue
$0000About PolyNovo
PolyNovo (ASX:PNV) develops and owns a biodegradable polymer - NovoSorb TM. PolyNovo develops regenerative devices for reconstructive surgery and tissue repair with its biodegradable polymer technology, NovoSorb. NovoSorb is a family of medical-grade polymers used to form medical devices to reconstruct or repair failed tissue.
PolyNovo Headquarter Location
2/320 Lorimer Street
Port Melbourne, Victoria, 3207,
Australia
+61 0386814050
PolyNovo Patents
PolyNovo has filed 4 patents.
The 3 most popular patent topics include:
- Polyurethanes
- Abdomen
- Digestive system imaging
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
6/1/2017 | 11/24/2020 | Polymers, Polyurethanes, Dicarboxylic acids, Biomaterials, Thermoplastics | Grant |
Application Date | 6/1/2017 |
---|---|
Grant Date | 11/24/2020 |
Title | |
Related Topics | Polymers, Polyurethanes, Dicarboxylic acids, Biomaterials, Thermoplastics |
Status | Grant |
Latest PolyNovo News
Aug 9, 2022
A government grant is set to boost the medical devices company's production capability. The post <strong>Why is the Polynovo share price powering 6% on Tuesday?</strong> appeared first on The Motley Fool Australia.
When was PolyNovo founded?
PolyNovo was founded in 1998.
Where is PolyNovo's headquarters?
PolyNovo's headquarters is located at 2/320 Lorimer Street, Port Melbourne.
What is PolyNovo's latest funding round?
PolyNovo's latest funding round is IPO.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.